(Q50980453)

26 March 2018

title

Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis. (English)

1 reference

26 March 2018

0 references

1 reference

1 reference

1 reference

9

Maxime Dougados

1 reference

26 March 2018

8

Bernard Combe

1 reference

26 March 2018

Xavier Mariette

10

object named as

Xavier Mariette

1 reference

26 March 2018

author name string

Jérémie Sellam

1

1 reference

26 March 2018

Stéphanie Rouanet

2

1 reference

26 March 2018

Houria Hendel-Chavez

3

1 reference

26 March 2018

Karim Abbed

4

1 reference

26 March 2018

Jean Sibilia

5

1 reference

26 March 2018

Jacques Tebib

6

1 reference

26 March 2018

Xavier Le Loët

7

1 reference

26 March 2018

Yassine Taoufik

11

1 reference

26 March 2018

publication date

1 December 2011

1 reference

26 March 2018

published in

Arthritis & Rheumatology

1 reference

26 March 2018

volume

63

1 reference

26 March 2018

issue

12

1 reference

26 March 2018

page(s)

3692-3701

1 reference

26 March 2018

Rituximab: a new therapeutic alternative in rheumatoid arthritis

cites work

1 reference

B cell depletion therapy in autoimmune diseases

21 January 2018

1 reference

Anti-CD20 therapy in patients with rheumatoid arthritis: predictors of response and B cell subset regeneration after repeated treatment

21 January 2018

1 reference

Management of nonresponse to rituximab in rheumatoid arthritis: predictors and outcome of re-treatment

21 January 2018

1 reference

Abnormalities in peripheral B cell memory of patients with primary Sjögren's syndrome

21 January 2018

1 reference

Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus.

21 January 2018

1 reference

Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus

21 January 2018

1 reference

Insights into the heterogeneity of human B cells: diverse functions, roles in autoimmunity, and use as therapeutic targets

21 January 2018

1 reference

Cutting edge: anti-tumor necrosis factor therapy in rheumatoid arthritis inhibits memory B lymphocytes via effects on lymphoid germinal centers and follicular dendritic cell networks

21 January 2018

1 reference

Disturbances in B- and T-cell homeostasis in rheumatoid arthritis: suggested relationships with antigen-driven immune responses.

21 January 2018

1 reference

Alterations in peripheral blood memory B cells in patients with active rheumatoid arthritis are dependent on the action of tumour necrosis factor

21 January 2018

1 reference

B-cell stage and context-dependent requirements for survival signals from BAFF and the B-cell receptor.

21 January 2018

1 reference

Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations

21 January 2018

1 reference

BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth

21 January 2018

1 reference

Expression of BAFF and BAFF-R in the synovial tissue of patients with rheumatoid arthritis.

21 January 2018

1 reference

Fibroblast-like synoviocytes of mesenchymal origin express functional B cell-activating factor of the TNF family in response to proinflammatory cytokines.

21 January 2018

1 reference

The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome

21 January 2018

1 reference

B-cell-activating factor receptor expression on naive and memory B cells: relationship with relapse in patients with rheumatoid arthritis following B-cell depletion therapy.

21 January 2018

1 reference

The B lymphocyte stimulator receptor-ligand system in hepatitis C virus-induced B cell clonal disorders.

21 January 2018

1 reference

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

21 January 2018

1 reference

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumati

21 January 2018

1 reference

Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells

21 January 2018

1 reference

Decreased frequency and activated phenotype of blood CD27 IgD IgM B lymphocytes is a permanent abnormality in systemic lupus erythematosus patients

21 January 2018

1 reference

Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjögren's syndrome.

21 January 2018

1 reference

Significantly depressed percentage of CD27+ (memory) B cells among peripheral blood B cells in patients with primary Sjögren's syndrome.

21 January 2018

1 reference

B cell depletion therapy in systemic lupus erythematosus

21 January 2018

1 reference

Circulating human B and plasma cells. Age-associated changes in counts and detailed characterization of circulating normal CD138- and CD138+ plasma cells

21 January 2018

1 reference

Interaction between synovial inflammatory tissue and bone marrow in rheumatoid arthritis.

21 January 2018

1 reference

Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome

21 January 2018

1 reference

Markers of B-lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohort

21 January 2018

1 reference

Highly sensitive B cell analysis predicts response to rituximab therapy in rheumatoid arthritis

21 January 2018

1 reference

Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ART.30599

1 reference

26 March 2018

1 reference

26 March 2018